PMID: 3756264Oct 1, 1986Paper

Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly

Biological Psychiatry
A GeorgotasT B Cooper

Abstract

This comprehensive study investigated both the role of antidepressant drugs in the treatment of affective disorders of later life and their safety with careful clinical and pharmacological monitoring. A 7-week double-blind comparison was made of the efficacy and safety of nortriptyline (a tricyclic), phenelzine (a monoamine oxidase inhibitor), and placebo. The results indicated a response rate of approximately 60% for both nortriptyline and phenelzine versus a 13% response rate for placebo. Anticholinergic side effects were more frequently reported in the nortriptyline group. Orthostatic symptoms were reported with similar frequency in both drug groups. Overall, both drugs were well tolerated.

References

May 1, 1978·Archives of General Psychiatry·D S RobinsonD Bartlett
Nov 1, 1979·The American Journal of Psychiatry·J W Ashford, C V Ford
Jun 1, 1978·Archives of General Psychiatry·R L SpitzerE Robins
Jul 1, 1977·The American Journal of Psychiatry·A NiesJ O Ives
Jan 1, 1972·The Journal of Clinical Pharmacology and New Drugs·A Raskin
Aug 7, 1971·British Medical Journal·M AsbergD Tuck
Sep 1, 1982·The American Journal of Psychiatry·B ReisbergT Crook
Jan 1, 1980·International Journal of Psychiatry in Medicine·D V SheehanN Kouretas

❮ Previous
Next ❯

Citations

Jan 1, 1992·The Psychiatric Quarterly·B S GreenwaldP Aupperle
Oct 29, 2011·European Archives of Psychiatry and Clinical Neuroscience·Thomas C BaghaiUNKNOWN Section of Pharmacopsychiatry, World Psychiatric Association
Oct 1, 1987·Biological Psychiatry·R C YoungH Kutt
Sep 1, 1989·Journal of Affective Disorders·A Georgotas, R E McCue
Jan 1, 1992·Archives of Gerontology and Geriatrics·S G Burchinsky, S M Kuznetsova
Apr 18, 1998·Journal of Affective Disorders·N MittmannN H Shear
Jun 10, 2000·British Journal of Clinical Pharmacology·C Parikh
Jan 1, 1993·Journal of the American Academy of Child and Adolescent Psychiatry·P J AmbrosiniJ Elia
Nov 24, 2004·Journal of Psychiatric Practice·Jess G Fiedorowicz, Karen L Swartz
Sep 24, 2008·Drugs & Aging·Tarek K RajjiCharles F Reynolds
Jan 22, 1996·Journal of Affective Disorders·A J Flint, S L Rifat
Aug 2, 2003·The Journal of Nervous and Mental Disease·George I PapakostasAndrew A Nierenberg
Jul 12, 2002·International Journal of Geriatric Psychiatry·P G MottramM Abou-Saleh
Feb 17, 2010·Neuropharmacology·Paul T FrancisMitchell K Lai
Dec 6, 2005·The Psychiatric Clinics of North America·Robert C Young
Jun 1, 1987·Biological Psychiatry·A GeorgotasJ Welkowitz
Mar 18, 2004·Clinics in Geriatric Medicine·Abhilash K Desai
Aug 23, 2005·Expert Opinion on Drug Safety·Liborio RampelloAlessandro Alvano
May 2, 2003·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·David C SteffensK Ranga Rama Krishnan
Apr 1, 1988·Journal of the American Geriatrics Society·R C YoungH Kutt
Jan 1, 1997·International Journal of Psychiatry in Medicine·D K Conn, A B Steingart
Aug 28, 2016·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Barnett S Meyers
Apr 3, 2001·Journal of Geriatric Psychiatry and Neurology·D Weintraub
Nov 25, 2003·The Annals of Pharmacotherapy·Pieter StolkThomas R Einarson
Oct 1, 1990·Journal of Geriatric Psychiatry and Neurology·B G PollockC F Reynolds
Jan 6, 2010·Pharmaceuticals·Rodrigo Machado-VieiraCarlos A Zarate
Jan 27, 2006·The Cochrane Database of Systematic Reviews·P MottramJ Strobl
May 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·A Flint
Jul 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·P Mallett
Jul 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·G M GoodwinM P Austin
Jul 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·A GeorgotasT B Cooper
Nov 1, 1987·Medical Toxicology and Adverse Drug Experience·J A Henry, A J Martin
Jun 19, 2001·The Cochrane Database of Systematic Reviews·K WilsonA Nightingale
Oct 1, 1994·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·A J Flint
Aug 1, 1989·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·B G Pollock, J M Perel
Mar 23, 2004·CNS Spectrums·Alastair J Flint

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The British Journal of Psychiatry : the Journal of Mental Science
A GeorgotasT B Cooper
The American Journal of Psychiatry
A Flint, J Silveira
© 2021 Meta ULC. All rights reserved